LY293111
Term · Oncology and biomedicine · MLC-T-ONC-005002
A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called leukotriene B4 receptor antagonists.
| Identifier | MLC-T-ONC-005002 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005002",
"term": "LY293111",
"field": "Oncology and biomedicine",
"definition": "A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called leukotriene B4 receptor antagonists.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ly293111/"
}
Record 10,436 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.